Cardiovascular Systems Inc (CSII) Annual Balance Sheets

Annual · GAAP · USD millions
Access CSII quarterly Balance Sheets →
Quarterly balance sheet trends provide context on Cardiovascular Systems Inc's liquidity, leverage, and long-term financial structure.
Annual Report, GAAP in USD millions
ITEM
(Jun 30 2022)
(Jun 30 2021) (Jun 30 2020) (Jun 30 2019) (Jun 30 2018)
Assets
Cash & cash equivalent66.42
Marketable Securities, Current SH93.41
Cash & Short-term Investments159.00
Accounts receivable39.68
Inventories34.57
Other Current Assets0.00
Prepaid Expense And Other Assets Current7.77
Total Current Assets241.85
Equipment/Property/Plant Net29.04
Intangible Assets15.73
Other Assets, Noncurrent36.06
Total Assets322.68
Liabilities
Accounts Payable, Current AC14.38
Accrued Liabilities, Current AC23.46
Other Liabilities, Current0.00
Deferred Revenue, Current DE2.11
Total Current Liabilities39.95
Total Long-term Debt0.00
Deferred Revenue, Noncurrent DE0.00
Other liabilities, Noncurrent12.95
Financing Obligation Long Term20.30
Total Liabilities73.20
Stockholders' Equity
Common Stock Value0.04
Additional Paid In Capital Common Stock673.39
Retained Earnings / Accumulated Deficit-423.68
Other Equity-0.27
Common Stockholder's Equity249.48
Total Stockholder's Equity249.48
Liabilities & Stockholder's Equity322.68
4 historic quarters locked

Sign in to unlock the full Cardiovascular Systems Inc balance sheet history.

About Cardiovascular Systems Inc Annual Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001180145-23-000016

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.